Who Paid My Doc
Brintellix
Drug Psychiatry
NDC 64764-550-30
General payments
$1,201,054
Research payments
$6,812,309
Through program year 2025, $1,201,054 in general payments and $6,812,309 in research payments were reported against Brintellix (Psychiatry).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
14 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $20,139 | 6 |
| 2025 | Research | $866,957 | 243 |
| 2024 | General | $61,573 | 541 |
| 2024 | Research | $630,361 | 165 |
| 2023 | General | $117,933 | 1,265 |
| 2023 | Research | $1,689,060 | 490 |
| 2022 | General | $181,694 | 2,360 |
| 2022 | Research | $738,711 | 218 |
| 2021 | General | $293,516 | 12,381 |
| 2021 | Research | $450,623 | 147 |
| 2020 | General | $149,165 | 5,474 |
| 2020 | Research | $612,472 | 182 |
| 2019 | General | $377,034 | 10,302 |
| 2019 | Research | $1,824,125 | 90 |
Breakdown
Each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
32,329 general · 1,535 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.